TrialJournal of substance abuse treatment2018

Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?

Peter D Friedmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.